[Abstract Only] Randomized Trial: Maintaining Low-dose Prednisone in SLE Patients with Inactive Disease Prevents Relapse
8 Jan, 2020 | 01:21h | UTCWithdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial – Annals of Rheumatic Diseases (link to abstract – $ for full-text)
Commentary: Fewer Lupus Flares on Low Dose Steroids – RheumNow (free)